DB05578 : a novel antiangiogenic agent . DB05578 ( IMC-1121B ) is a fully humanized monoclonal antibody that binds to P35968 and can inhibit angiogenesis , a quintessential mechanism for promoting tumor growth and metastasis . Several antiangiogenesis agents are already approved for cancer therapy ; however , ramucirumab 's selectivity for P35968 makes it interesting . The selectivity of an agent can improve safety and efficacy . This article describes the mechanism of action , pharmacokinetics , safety and clinical trial results of ramucirumab with particular emphasis on gastric cancer .